U.S. Markets open in 6 hrs 46 mins

Stereotaxis, Inc. (STXS)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.7900+0.0400 (+2.29%)
At close: 04:00PM EDT
1.8900 +0.10 (+5.59%)
After hours: 07:49PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.7500
Bid1.7900 x 800
Ask1.8000 x 1000
Day's Range1.7800 - 1.8250
52 Week Range1.7200 - 10.3000
Avg. Volume408,959
Market Cap133.5M
Beta (5Y Monthly)1.56
PE Ratio (TTM)N/A
EPS (TTM)-0.1310
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.67
  • Motley Fool

    Stereotaxis (STXS) Q1 2022 Earnings Call Transcript

    Thank you for joining us for Stereotaxis first quarter 2022 earnings conference call. On the heels of last year, where we demonstrated a restart in capital adoption and overall sales growth, our primary challenge has been driving consistent momentum and growth in capital activity.

  • Zacks

    Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates

    Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of 0% and 0.53%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Stereotaxis Reports 2022 First Quarter Financial Results

    ST. LOUIS, May 10, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the first quarter ended March 31, 2022. “Stereotaxis demonstrated continued progress on capital adoption despite a challenging macro environment,” said David Fischel, Chairman and CEO. “We are focused on improving our internal commercial capabilities while navigating the external challenges an